09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

Oncology<br />

PO-ONC-01<br />

Iridocorneal Endothelial (ICE) Syndrome masquerading as Iris<br />

Melanoma in 71 cases<br />

Shields Carol L. (1) , Shields Margaret V. (1) , Say Emil Anthony T. (1) , Shields<br />

Jerry A. (1)<br />

1. Wills Eye Institute<br />

Purpose: To describe the features <strong>of</strong> iridocorneal endothelial (ICE) syndrome<br />

in group <strong>of</strong> patients referred because <strong>of</strong> suspected iris melanoma.<br />

Methods: Chart review <strong>of</strong> 71 patients<br />

Results: The median patient age was 54 years. All were referred for evaluation<br />

<strong>of</strong> possible iris melanoma. The mass proved to be a combination <strong>of</strong> iris stromal<br />

atrophy in 41 cases (58%) with exposure or loss <strong>of</strong> underlying iris pigment<br />

epithelium, ectropion iridis in 24 (34%) imparting a disfigured iris with dark<br />

brown color, iris nodules in 5 (7%), traction elevation with iris distortion from<br />

peripheral anterior synechia in 57 (80%), and corectopia in 53 (75%), a feature<br />

commonly found with iris melanoma. The extent <strong>of</strong> iris atrophy was mean 2<br />

clock hours. Ectropion iridis was unidirectional in 10 and multidirectional in<br />

14. No case demonstrated polycoria. Additional features <strong>of</strong> ICE included<br />

corneal endothelial guttata in 33 (46%), corneal edema in 7 (10%), iris pigment<br />

epithelial transillumination defects in 12 (17%), and secondary glaucoma with<br />

intraocular pressure above 22 mm Hg in 7 (10%).<br />

Conclusions: ICE syndrome can simulate iris melanoma. Features more<br />

suggestive <strong>of</strong> ICE syndrome include corneal endothelial guttata and edema,<br />

peripheral anterior synechia, multidirectional ectropion iridis, and iris atrophy.<br />

PO-ONC-02<br />

Epibulbar Osseous Choristoma in 8 Patients<br />

Shields Carol L. (1) , Qureshi Anam (1) , Eagle, Jr. Ralph C. (1) , Lally Sara E. (1) ,<br />

Shields Jerry A. (1)<br />

1. Wills Eye Institute<br />

Purpose: To describe clinical features <strong>of</strong> epibulbar osseous choristoma<br />

Methods: Chart review<br />

Results: At diagnosis, the median patient age was 19 years, 6 were female,<br />

and 6 were Caucasian, 1 Hispanic, and 1 African-American. There were no<br />

syndromes. The choristoma was superotemporal (n=8), located in the fornix<br />

(n=4) or equatorial bulbar conjunctiva (n=4), deep to Tenon›s fascia (n=8), and <strong>of</strong><br />

yellow (n=2), white (n=2), or pink (n=4) color. The median basal dimension was<br />

median 10 mm and thickness was 4 mm. Management included observation<br />

(n=4) or surgical excision (n=4). There was no growth or recurrence.<br />

Conclusions: Episcleral osseous choristoma is an isolated tumor <strong>of</strong> mature<br />

bone located superotemporally near the fornix in young patients.<br />

PO-ONC-03<br />

Cytogenetic Testing <strong>of</strong> Iris Melanoma using Fine Needle Aspiration<br />

Biopsy in 17 cases<br />

Shields Carol (1) , Ramasubramanian Aparna (1) , Ganguly Arupa (1) , Mohan<br />

Diwakar (1) , Shields Jerry A. (1)<br />

1. Wills Eye Institute<br />

Purpose: To determine chromosome 3 monosomy in iris melanoma<br />

Methods: FNAB for genetic analysis (DNA amplification and microsatellite<br />

assay)<br />

Results: Disomy 3 was found in 5 melanomas, partial monosomy 3 in 7, and<br />

complete monosomy 3 in 5. The only feature associated with partial/complete<br />

monosomy 3 was older median patient age (p=0.03). Monosomy 3 melanomas<br />

were thinner (diffuse melanoma) and with greater iris/angle seeding producing<br />

elevated intraocular pressure. Monosomy 3 tumors showed mixed/epithelioid<br />

cell type in 80% vs. 0% in disomy 3 (p=0.14). No patients developed local<br />

metastasis over 16-month mean follow up.<br />

Conclusions: Using FNAB, iris melanoma demonstrated partial or complete<br />

monosomy 3 in 71%, correlating with increasing patient age.<br />

568<br />

PO-ONC-04<br />

Ophthalmoscopic differentiation <strong>of</strong> Coats› Disease from<br />

Retinoblastoma<br />

Shields Jerry (1) , Shields Carol (1)<br />

1. Wills Eye Institute<br />

Background/Purpose: Coats disease (CD) is <strong>of</strong>ten confused clinically with<br />

retinoblastoma. It is important for clinical and legal reasons to differentiate<br />

them. This study was to delineate the features that differentiate CD and<br />

retinoblastoma. Approximately 1400 patients with retinoblastoma and 175<br />

with CD had fundus drawings, photography, fluorescein angiography, and<br />

ultrasonography These were reviewed to establish clinical criteria that serve to<br />

differentiate these conditions.<br />

Results: Features that differed in CD and retinoblastoma included nature <strong>of</strong><br />

pupillary reflex, color <strong>of</strong> subretinal fluid, and caliber and distribution <strong>of</strong> the<br />

retinal blood vessels. The pupillary reflex and color <strong>of</strong> subretinal material<br />

are generally yellow in CD and white to gray with retinoblastoma. Macular<br />

involvement with CD shows yellow exudation, whereas macular involvement<br />

with retinoblastoma shows a white mass. The retinal blood vessels in CD<br />

disease are irregular in caliber, whereas in retinoblastoma the retinal vessels<br />

are uniformly dilated and more tortuous. The blood vessels in CD remain visible<br />

from the posterior to the peripheral fundus, whereas those retinoblastoma tend<br />

to disappear into the adjacent neoplasm.<br />

Conclusion: Despite their superficial similarities CD and retinoblastoma usually<br />

have different clinical features. Recognition <strong>of</strong> these differences can avoid<br />

erroneous diagnosis, misdirected therapy and legal repercussions.<br />

PO-ONC-05<br />

Sentinel episcleral vessels and intraocular malignant tumors<br />

Li Juanjuan (1)<br />

1. Department Ophthalmology<br />

Objective: To investigate the relevance <strong>of</strong> the sentinel vesseland intraocular<br />

malignant tumors?The probability were analyzed for the diagnosis and<br />

differential diagnosis <strong>of</strong> intraocular malignant tumors.<br />

Methods: To observe the patients diagnosed iris and choroid malignant<br />

melanoma, analyze the scleral surface sentinel vesselfeatures.<br />

Results: The sentinel incidence was 32%in the intraocular malignant tumor<br />

patients, located in the sclera shallow, showing segmental expansion, within<br />

the tumor in the same quadrant.<br />

Conclusion: Sentinel vessels, with tumor growth rate, uneven pigment<br />

distribution can improve the accuracy <strong>of</strong> diagnosis <strong>of</strong> intraocular malignant<br />

tumors.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!